Form 8-K - Current report:
SEC Accession No. 0001835268-26-000006
Filing Date
2026-03-30
Accepted
2026-03-30 07:06:04
Documents
17
Period of Report
2026-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cntb-20260329.htm   iXBRL 8-K 42658
2 EX-10.1 exhibit101-securitiespurch.htm EX-10.1 334888
3 EX-99.1 exhibit991-phase1ivstudypr.htm EX-99.1 24991
4 EX-99.2 exhibit992-radiantadstudyp.htm EX-99.2 25277
5 EX-99.3 exhibit993-pipepressrelease.htm EX-99.3 11903
9 image_0a.jpg GRAPHIC 143
10 image_1a.jpg GRAPHIC 138
  Complete submission text file 0001835268-26-000006.txt   653395

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntb-20260329.xsd EX-101.SCH 1806
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntb-20260329_lab.xml EX-101.LAB 22498
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntb-20260329_pre.xml EX-101.PRE 13245
21 EXTRACTED XBRL INSTANCE DOCUMENT cntb-20260329_htm.xml XML 2828
Mailing Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130
Business Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40212 | Film No.: 26809942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)